The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines.

The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development.

The inaugural session of the programme was graced by Ms. Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity.

Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine.

Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines.

During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs.

Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry.

The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units.

This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India’s leadership in the global regulation, standardization and development of traditional systems of medicine.

***

SR/SV/SG

(Release ID: 2262543) Visitor Counter : 176